throbber
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, May 1990, p. 129~1302
`0099-2240/90/051296-07$02.00/0
`Copyright © 1990, American Society for Microbiology
`
`Vol. 56, No.5
`
`Improved Expression of Human Interleukin-2 in High-Cell-Density
`Fermentor Cultures of Escherichia coli K-12 by a
`Phosphotransacetylase Mutant
`KEITH A. BAUER, ARIE BEN-BASSAT, MIKE DAWSON, VIRGINIA T. DE LA PUENTE,
`AND JUSTIN 0. NEWA Y*
`Department of Fermentation Research and Development, Cetus Corporation, 1400 Fifty-third Street,
`Emeryville, California 94608
`
`Received 13 November 1989/Accepted 12 February 1990
`
`A fluoroacetate-resistant mutant of Escherichia coli K-12 (MM-294) accumulated less acetate in the medium
`during growth to high cell density in fermentor cultures and was shown to be defective in ito; phosphotrans(cid:173)
`acetylase activity. The mutant had an improved ability to continue growing during induction of interleukin-2
`(IL-2) synthesis, and in fermentor cultures it gave a higher level of specific IL-2 accumulation than its parent
`during expression under control of the temperature-sensitive PL promoter. In flask cultures at lower cell
`density, the mutant again produced less acetate than the parent, although both showed a much lower level of
`acetate accumulation than that seen in fermentors at high cell density. Both showed a higher specific expression
`level of IL-2 in flask cultures, and there was a greater ditference between the mutant and its parent in the final
`extent of specific IL-2 accumulation in fermentor cultures compared with flask cultures. Thus, the concentra(cid:173)
`tion of acetate in the medium, which was much higher in fermentor cultures (2:300 mM after 5 h of induction)
`than in flask cultures (:53 mM) of the parent organism, was a significant factor in limiting expression of the
`heterologous protein product, IL-2. The acetate kinase-phosphotransacetylase pathway was therefore a major
`source of acetate formation in these cultures. Blocking this pathway improved accumulation of IL-2 and did not
`slow growth.
`
`Organic acids accumulate in the culture medium during
`aerobic growth of Escherichia coli on glucose (17). The most
`abundant organic acid is often acetic, and its concentration
`can build up to levels that are inhibitory to growth (1, 13).
`In a previous study (10), we showed that intracellular
`accumulation of interleukin-2 (IL-2), under control of the
`temperature-sensitive bacteriophage lambda PL promoter,
`was inversely correlated with cell density and acetate accu(cid:173)
`mulation in fermentor cultures. These observations provided
`circumstantial evidence that acetate was at least partially
`responsible for the cessation of product accumulation during
`expression of heterologous genes in E. coli and suggested
`that higher levels of IL-2 accumulation could be expected if
`acetate formation could be blocked.
`Two enzymatic pathways for acetate formation in E. coli
`have been identified. Acetate can be derived directly from
`pyruvate by pyruvate oxidase, but the activity of this en(cid:173)
`zyme in E. coli is thought to be too low to account for the
`amount of acetate produced (4). Acetate can also be derived
`from acetylcoenzyme A (CoA) by the acetate kinase-phos(cid:173)
`photransacetylase (ACK-PTA) pathway (3). In E. coli B,
`PTA is activated by pyruvate and inhibited by NADH (14).
`The genes coding for PTA and ACK have been mapped and
`form an operon in E. coli and Salmonella typhimurium which
`is induced as much as twofold under anaerobic conditions
`(8). Mutants defective in both activities can be isolated by
`selection for fluoroacetate resistance (3).
`In the work presented here, we examined the role of the
`ACK-PTA pathway in the formation of acetate during intra(cid:173)
`cellular accumulation of IL-2. We isolated 52 fluoroacetate(cid:173)
`resistant mutants from E. coli MM294-1 and partially char-
`
`* Corresponding author.
`
`acterized them. Some of these mutants had reduced acetate(cid:173)
`forming ability, as low as 10 to 20% of parental levels in flask
`cultures, with near-normal aerobic growth rates on glucose.
`We describe here the characterization of one of these
`mutants and its performance as a host strain for PL promot(cid:173)
`er-driven accumulation of IL-2.
`
`MATERIALS AND METHODS
`Strains. All strains used in this study were derived from E.
`coli K-12 and are listed in Table 1. Phage stocks used for
`testing cl857 function were the gift of D. Gelfand. HW21 was
`the gift of H. C. Wong. The poxB strains were the gift of
`J. E. Cronan and the pta-ack deletion strains were the gift of
`G. F.-L. Ames.
`Media. N8-2 medium consisted of NH4Cl (10 mM),
`KH2P04 (21.9 mM), Na2HP04 (28.1 mM), K2S04 (9 mM),
`MgS04 (0.2 mM), MnS04 (3 JJ.M), ZnS04 (3 JJ.M), and
`CuS04 (0.1 JJ.M) in deionized water. The medium was
`sterilized by autoclaving, after which the following sterile
`additions were made: glucose (2 g/liter); thiamine hydrochlo(cid:173)
`ride (10 mg/liter); FeS04 (10 JJ.M).
`Minimal agar plates were of similar composition to defined
`flask medium (see below), except that the trace metals
`solution was 1 mllliter, MgS04 was at 1 mM, and agar was
`added to 1.5% (wt/vol). Alternate carbon sources (galactose
`or sodium pyruvate) were also used at 5 g/liter. Ampicillin
`(50 mg/liter) and tetracycline (15 mg/liter) were used as
`indicated. Sodium monofluoroacetate (Tull Chemical Co.,
`Inc., Oxford, Ala.) was added to 25 mM as indicated.
`R2-4 agar plates were standard rich-medium plates de(cid:173)
`scribed elsewhere (10).
`Isolation plates were composed ofN~HP04 (5.68 g/liter),
`KH2P04 (3.54 g/liter), trisodium citrate · 2H20 (0.44 g/liter),
`a solution containing ZnS04 (30 mM), MnS04 (30 mM), and
`
`1296
`
`BEQ 1029
`Page 1
`
`

`
`VoL. 56, 1990
`
`PTA- MUTANT OF E. COLI SHOWING IMPROVED IL-2 EXPRESSION
`
`1297
`
`TABLE 1. Strains used
`
`Strain
`
`Relevant characteristics
`
`Source
`
`DG116
`
`cl857+, derived from
`MM294-1
`Thi+ derivative of 00116
`HW21
`HW21(pFC54.t) TS 11 copy number (16), PL(cid:173)
`IL-2 (15) in HW21
`Thi+ derivative of MD050
`KB100
`KB100(pFC54.t) TS copy number (16), PL-
`IL-2 (15) in KB100
`Pta-
`MD050
`Pta-, cl857+ (lysogen)
`MD050L
`MD050L(pFC54.t) TS copy number (16), PL-
`IL-2 (15) in MD050L
`Tn5 inserted into poxB
`(PoxB-)
`endAJ hsdR17 supE thi,
`derived from MM294 (11)
`Gal- strain for P1
`transduction
`pta
`ack
`ll(ack, pta, hisP-hisQ)
`Ack+ Pta+
`TnlO inserted near poxB
`(PoxB+)
`
`MH6
`
`MM294-1
`
`MM294-1
`galE::TnlO
`TA3514
`TA3515
`TA3516
`TA3521
`YYC201
`
`CMcca
`
`CMCC
`This work
`
`This work
`This work
`
`This work
`This work
`This work
`
`J. E. Cronan
`
`CMCC
`
`D. Gelfand
`
`G. F.-L. Ames
`G. F.-L. Ames
`G. F.-L. Ames
`G. F.-L. Ames
`J. E. Cronan
`
`trifuged at 28,000 x g for 60 min at 5°C and stored at - 20°C
`prior to use.
`(ii) PTA activity. PTA activity was measured by the
`method of Brown et al. (3). In this assay, the conversion of
`acetylphosphate to acetyl-CoA is coupled to NADH forma(cid:173)
`tion through malate dehydrogenase and citrate synthase.
`The reaction mixture contained the following components in
`1 ml: Tris hydrochloride (pH 8.0 at room temperature), 100
`JJ.mol; MgCl2 , 5 JJ.mol; NAD+, 0.5 JJ.mol; CoA, 0.5 JJ.mol;
`malate, 5 JJ.mol; acetylphosphate, 10 JJ.mol; malate dehydro(cid:173)
`genase, 27.5 U; and citrate synthase, 6.75 U. One unit of
`PTA activity was defined as the amount of enzyme required
`to allow the formation of 1 JJ.mol of NADH per min.
`(iii) ACK activity. ACK activity was measured by the
`method of Fox and Roseman (6). In this assay, ADP forma(cid:173)
`tion from A TP and acetate is coupled to NADH consump(cid:173)
`tion through pyruvate kinase and lactate dehydrogenase.
`The reaction mixture contained the following components in
`1 ml: PIPES [piperazine-N,N'-bis(2-ethanesulfonic acid)](cid:173)
`KOH (pH 7.0 at room temperature; Sigma Chemical Co.), 50
`JJ.mol; glycerol, 100 mg; MgCl2 , 5 JJ.mol; dithiothreitol, 1
`JJ.mol; phosphoenolpyruvate, 7 JJ.mol; potassium acetate, 300
`JJ.mol; ATP, 30 JJ.mol; NADH, 1 IJ.mol; pyruvate kinase, 50
`U; and lactate dehydrogenase, 10 U. One unit of ACK
`activity was defined as the amount of enzyme required to
`allow the oxidation of 1 JJ.mol of NADH per min.
`For both enzyme assays, the reactions were started by
`addition of extract and followed by measuring the change in
`A340 over time at room temperature, using a Hewlett(cid:173)
`Packard HP8452A spectrophotometer equipped with en(cid:173)
`zyme kinetics software. PTA activity was shown to be
`completely dependent on the presence of both primary
`substrates, acetylphosphate and CoA. ACK activity was
`dependent on the presence of A TP and was greatly reduced
`but not eliminated when acetate was omitted. This was
`probably due to the presence of other A TPases in the crude
`extracts. Boiling the extracts eliminated all activity in both
`assays. Both assays were used in the linear range of enzyme
`activity.
`Genetic techniques. (i) Selection of low-acetate-producing
`strains. The ACK-PTA pathway is bi-directional and allows
`entry of acetate into central metabolism via acetyl-CoA.
`Mutants with low acetate-producing ability were therefore
`selected by isolating strains resistant to the tricarboxylic
`acid cycle inhibitor fluoroacetate (3, 9). E. coli MM294-1 was
`grown in nutrient broth to a cell density of approximately 2.0
`OD680 (approximately 3 x 1lf' cells per ml). Cells were then
`plated at approximately 2 x 107 , 2 x 108 , and 2 x 109 cells
`per plate on isolation plates containing either lactate plus
`fluoroacetate or pyruvate plus fluoroacetate and incubated at
`37°C for 3 days. A total of 52 individual colonies were picked
`from these plates, streaked for isolation onto the same
`selective medium, and incubated at 37°C. Because there was
`still perceptible growth of carry-over wild-type cells on some
`plates, the 52 isolates were again picked from single colo(cid:173)
`nies, streaked for a second time onto fresh plates containing
`the same selective medium, and incubated at 37°C. Single
`colonies were again picked after 48 h, suspended in 1 ml of
`saline, and streaked for a third time onto fresh selective
`medium. The same isolates were also streaked onto medium
`containing acetate as sole carbon source to test for differ(cid:173)
`ences in ability to grow on acetate.
`Strains were evaluated for acetate production and growth
`rate by inoculating 125-ml flasks containing 25 ml of pre(cid:173)
`warmed N8-2 medium at an initial cell density of0.05 OD680•
`Cultures were incubated at 37°C on a New Brunswick rotary
`
`a CMCC, Cetus Master Culture CoUection.
`b TS, Temperature sensitive.
`
`CuS04 (30 mM) at 0.2 ml/liter; (NH4hS04 (2.0 g/liter),
`MgS04 • 7H20 (102 mg/liter), and agar (1.5%, wt/vol). The
`liquid was sterilized by autoclaving, and the following sterile
`additions were made: FeS04 (200 mM) in 2.5 mM H2S04 ,
`0.36 mVliter, CaCl2 (1.0 M), 0.1 mVliter, thiamine hydrochlo(cid:173)
`ride (1.0%), 2.0 mVliter. Pyruvate, lactate, acetate, or glu(cid:173)
`cose was added at 0.5% (wt/vol) as carbon source. Sodium
`monofluoroacetate was added at a concentration of 25 mM
`along with lactate or pyruvate to select for putative mutants
`with reduced ability to produce acetate.
`Defined flask medium consisted of trisodium citrate (4
`mM), (NHJ2S04 (10 mM), KH2P04 (50 mM), and trace
`metals solution (2) (4 mVliter). The pH of the medium was
`adjusted to 6.8 with NaOH, and the solution was autoclaved.
`Glucose (5 g/liter), thiamine hydrochloride (20 mg/liter), and
`MgS04 (3 mM) were added to the cooled medium from
`sterile concentrated stock solutions.
`For fermentor medium, the medium of Bauer and Shiloach
`(2) with some modifications was used as described previ(cid:173)
`ously (10), except that 20 mg of thiamine hydrochloride per
`liter was added after autoclaving. The 14-liter Chemap
`fermentors as well as inoculation and operating conditions
`used in this study were as described previously (10).
`Assays. Assays for acetate, cell growth, and IL-2 in
`isolated refractile bodies, as well as the various conversion
`factors used, were as described previously (10).
`(i) Preparation of ceU extracts. Cell extracts for assays of
`PTA and ACK activities were prepared as follows: 100 ml of
`a defined flask medium culture in exponential growth was
`centrifuged at 3,000 x g for 10 min at 5°C and then washed
`twice in 30 ml of 10 mM sodium phosphate buffer, pH 7.5 (at
`room temperature), which included 10 mM MgCl2 and 1 mM
`EDTA. The cells were suspended in the same buffer to a final
`total protein concentration of 2 to 2.4 mg/ml (based on
`optical density at 680 nm [OD680] converted to protein
`content) and sonicated on ice to completion (approximately
`5 min, microscopic observation). Sonic extracts were cen-
`
`BEQ 1029
`Page 2
`
`

`
`1298
`
`BAUER ET AL.
`
`APPL. ENVIRON. MICROBIOL.
`
`shaker at 200 rpm, and density readings were taken approx(cid:173)
`imately every 0.5 h. At approximately 1.2 OD680, small
`culture samples were taken for acetate analysis. Many of the
`52 isolat«:s showed greatly reduced acetate. accumulation,
`some as httle as 10% of parental levels. Stram MD050 were
`selected for further experimentation because it consistently
`gave the lowest levels of acetate accumulation and had a
`growth rate essentially indistinguishable from that of its
`parent (approximately 0.6 h- 1).
`(ii) Pl transduction. Genetic elements coding for markers
`such as cl857, Thi+, and poxB::Tn5 were transferred by Pl
`transduction, essentially as described by Miller (12). To
`select for cl857, recipient strains were first made Gal-, using
`a lysate grown on MM294:ga/E::Tnl0. This intermediate
`was then transduced back to Gal+ by using a lysate grown on
`DG116 (a strain containing cl857 in the chromosome). Col(cid:173)
`onies were screened for cotransduction of the tightly linked
`cl857 marker by testing for lambda resistance at 30 and 41 oc.
`To select for the Thi+ phenotype, strains were plated on
`minimal glucose agar plates without thiamine. The resulting
`colonies were restreaked for purity and then grown in
`glucose-containing defined flask medium lacking thiamine to
`confirm that their growth rate in this medium was identical to
`that of the parent strain in thiamine-containing medium.
`(iii) poxB-containing strains. To create a Pta- poxB double
`mutant, the poxB::Tn5 mutation from MH6 was transduced
`into KB100. To confirm that the poxB mutation had been
`transferred, a lysate was grown on the putative double
`mutant and used to transduce YYC201 to kanamycin resis(cid:173)
`tance. The resulting transductants were shown to be poxB on
`pyruvate tetrazolium plates, as described by Chang and
`Cronan (5).
`
`RESULTS
`Characterization of MDOSO. (i) PTA activity. Selection for
`fluoroacetate resistance results in mutations in at least two
`genes, pta and ack (3, 9). MD050 was a presumptive Pta(cid:173)
`mutant based on its reduced acetate secretion levels and
`slow growth rate on acetate-containing plates. To confirm
`this, PTA and ACK activities were compared
`in
`MD050L(pFC54.t) and HW21(pFC54.t) grown at 30°C in
`defined me~ium. The two host strains were isogenic, except
`for the les10n recovered by fluoroacetate selection; they
`were both derived from the same MM294-1 parent. The only
`other difference between them was that HW21 was Thi+
`allowing it to grow without the addition of thiamine to th~
`medium. This change made no discernible difference to
`either acetate formation or IL-2 expression in HW21 when
`compared with its parent MM294-1 (data not shown). All
`defined media used here included thiamine.
`Three sets of extracts were prepared on separate days
`from shake flask cultures grown at 30°C (i.e., repressed IL-2
`expression). The results (Table 2) clearly showed that
`MD050L had greatly reduced PTA activity. No PTA activity
`was detected in the mutant in the first set of assays (detec(cid:173)
`tion limit, <1% of wild type), and small amounts (1.5% or
`less of wild type) were detected in the subsequent two tests.
`The low PTA activity in the second extract of MD050L
`(Table 2, set 2) was dependent on the presence of
`acetylphosphate in the assay mixture, but was still present
`when CoA was omitted. Furthermore, doubling the amount
`of Co A in the reaction mix inhibited the residual PTA
`activity in MD050L extracts. In contrast, the PTA activity in
`HW21 extracts had the expected dependence on both CoA
`and acetylphosphate. A comparison of ACK and PTA levels
`
`TABLE 2. Specific enzyme activities of PTA and ACK
`
`Strain
`
`Set 1
`HW21(pFC54. t)
`MD050L(pFC54. t)
`
`Set 2
`HW21(pFC54.t)
`MD050L(pFC54. t)
`
`Set 3
`HW21(pFC54.t)
`MD050L(pFC54. t)
`
`Activity (U/mg of protein)
`
`PTA
`
`1.2
`<0.01
`
`0.48
`0.007
`
`1.5
`0.002
`
`ACK
`
`0.45
`1.2
`
`0.26
`0.40
`
`0.14
`0.19
`
`in samples sonicated for different lengths of time (data not
`shown) showed that release of ACK activity was maximal
`under the sonication conditions used to generate the assay
`results shown in Table 2. Further sonication resulted in a
`small increase in the PTA activity seen in HW21 extracts,
`but the minute amount of activity seen in MD050L extracts
`was lost altogether. The observed enzyme activity differ(cid:173)
`ences were therefore not due to differences in the extent of
`cell breakage between the two strains, and the small amount
`of apparent PTA activity in MD050L was probably due to an
`activity other than normal PTA.
`ACK activity in the mutant strain was higher than that in
`the PTA-competent strain by 2.7-fold in the first assay,
`1.5-fold in the second, and 1.3-fold in the third assay.
`Enhanced ACK activity in pta mutants has not been re(cid:173)
`ported in the literature; in fact, in one report, mutations in
`pta were said to have no effect on ACK activity (3).
`(ii) Acetate accumulation. To determine the extent of
`acetate accumulation in flask cultures, HW21 (Pta+) and
`KB100 (Pta-) were grown for 15 generations in glucose(cid:173)
`containing defined medium at 30°C to achieve balanced
`growth and to eliminate carry-over of undefined nutrients
`from the inoculum. Growth and acetate accumulation rates
`were measured over an OD680 range of 0.02 to 0.3 in which
`growth was exponential and the supply of nutrients (includ(cid:173)
`ing oxygen) was not limiting. Data from these experiments
`are shown in Table 3. The Pta- mutant and nonmutant
`strains both had very similar specific growth rates of 0.59 to
`0.60 h- 1 • The specific acetate production rate of KB100 in
`
`TABLE 3. Growth rate and acetate production
`
`Expt and straina
`
`Expt 1 (flask
`cultures)
`HW21
`HW21(pFC54.t)
`KB100
`
`Expt 2 (flask
`cultures)
`TA3521
`TA3514 (pta)
`T A3515 (ack)
`T A3516 [~(ack-
`pta-hisQ-hisP)]
`
`Specific growth
`rate (h- 1)
`
`300C
`
`37"C
`
`Specific acetate
`production
`(mmollg [dry wt}
`per h)
`
`0.60
`0.50
`0.59
`
`0.69
`0.55
`0.49
`0.56
`
`4.62
`3.55
`0.59
`
`6.07
`1.38
`2.74
`1.40
`
`a Medium and conditions were as described in the text.
`
`BEQ 1029
`Page 3
`
`

`
`VoL. 56, 1990
`
`PTA- MUTANT OF E. COLI SHOWING IMPROVED IL-2 EXPRESSION
`
`1299
`
`E c
`0 co 100.0
`~
`>-
`+-'
`·u;
`c
`Q.l
`0
`ro
`(.)
`+-' a.
`0
`Q.l
`"-
`::J
`+-'
`
`10.0
`
`"S u
`
`~
`100.0 s
`
`c
`0
`+-'
`ro
`"-
`+-'
`c
`Q.l
`(.) c
`0
`u
`
`10.0
`
`Q.l
`+-' ro
`+-'
`Q.l
`(.)
`<(
`
`3.0
`15
`
`16
`
`17
`
`18
`
`3.0
`19
`
`Culture Age (Hours)
`FIG. 1. Mock inductions in fermentor cultures: growth (closed
`symbols) and acetate production (open symbols) during mock in(cid:173)
`ductions of the Pta- mutant MD050 (triangles) and a Pta nonmutant
`strain, HW21 (circles). In each case, the temperature was shifted
`from 30 to 37•c when the 00680 reached 20.
`
`these flask cultures was approximately sevenfold lower than
`that of HW21.
`To explore acetate accumulation by the Pta- mutant in
`fermentor cultures, mock inductions of strains MD050 and
`HW21 were performed by shifting the temperature from 30
`to 37•c at an 00680 of 20. These two strains did not contain
`plasmid and thus did not express IL-2. The results are shown
`in Fig. 1. The Pta- mutant and nonmutant strains had similar
`growth kinetics at both temperatures, while specific acetate
`production in the mutant was lower by a factor of approxi(cid:173)
`mately twofold. Specific acetate production rates were lower
`in fermentors than in flasks for both strains, with the
`difference being more pronounced in HW21 than in MD050.
`This may have been due to simple inhibition of the reversible
`ACK-PT A pathway, caused by the higher levels of acetate in
`the medium of fermentor cultures of HW21. There was little
`change in specific acetate production rates in the parent
`strain before and after mock induction. This was in contrast
`to the increase of 16-fold in specific acetate productivity that
`occurs when PTA-competent cells contain a plasmid allow(cid:173)
`ing IL-2 expression (10).
`Acetate accumulation in flasks was also measured in an
`isogenic set of E. coli K-12 strains which included a different
`pta mutant (T A3514) and a pta-ack double deletion mutant
`(T A3516). These strains were grown in defined medium plus
`histidine (100 1-Lg/ml to satisfy an auxotrophic requirement) at
`37•c for 20 h prior to analyzing the supernatant for acetate.
`Both the deletion strain and our Pta- strain (MD050) were
`found to produce lower amounts of acetate compared with
`their respective nonmutant parents (Table 3).
`Finally, we studied the effect of a mutation in pyruvate
`oxidase (poxB) on acetate accumulation in our Pta- mutant.
`A Tn5 insertion in the pyruvate oxidase gene was transferred
`into KB100 by P1 transduction. Acetate accumulation and
`
`growth rate in this double mutant were measured in glucose(cid:173)
`containing defined medium at 37•c and were found to be
`indistinguishable from those in its parent.
`EIJ'ect of the Pta- mutation on IL-2 production. The effects
`of the Pta- mutation on acetate and IL-2 accumulation were
`examined in flask and fermentor cultures, after lysogenizing
`KB100 (Table 1) to carry the cl857 gene in the chromosome,
`and transforming both it and HW21 with a plasmid (pFC54.t)
`which allowed intracellular accumulation of IL-2 under
`control of the temperature-sensitive PL promoter.
`(i) Shake Basks. Cultures, 100 ml, of KB100(pFC54.t) and
`HW21(pFC54.t) (Table 1), growing exponentially in glucose(cid:173)
`containing defined medium, were added to 400-ml portions
`of prewarmed (38°C) fresh medium in Fembach flasks and
`shaken at 3s•c for up to 5 h. Samples for high-pressure liquid
`chromatography analysis of IL-2 were taken at 3 and 5 h of
`induction. Growth kinetics were similar in the two strains,
`with the mutant growing slightly more in the later hours of
`induction, while specific acetate accumulation was calcu(cid:173)
`lated to be approximately sevenfold higher in the parent
`strain than in the mutant. IL-2 expression (as a percentage of
`total intracellular protein) after 3 and 5 h was 16 and 19%,
`respectively, for the HW21 strain and 18 and 21%, respec(cid:173)
`tively, for the KB100 strain. Therefore, the Pta- mutation
`resulting in lower acetate accumulation in KB100 did not
`negatively affect either growth or IL-2 accumulation and
`may have enhanced them slightly.
`(ii) Fermentor cultures. M0050L(pFC54.t) was grown in a
`fermentor as described above and induced by shifting the
`temperature from 30 to 37•c at cell densities of approxi(cid:173)
`mately 20 and 40 00680 in two separate runs. For compari(cid:173)
`son, HW21(pFC54.t) was grown similarly, with induction of
`IL-2 expression by temperature shift at 20 and 40 00680 • The
`kinetics of growth, acetate production, and IL-2 expression
`in these experiments are presented in Fig. 2. While both
`strains had a similar 2.5-fold increase in 00680 in the first 3
`h of induction in flasks, the Pta+ strain stopped growing after
`a cell density increase of only 1.6-fold in the 20-00680
`fermentor induction and 1.5-fold in the 40-00680 fermentor
`induction. In contrast, the Pta- mutant grew substantially
`more during induction at both cell densities. Specific acetate
`production during the 5-h induction period was seven- to
`ninefold less for the mutant than for the wild type at the
`different cell densities tested.
`Specific IL-2 accumulation in the transformed Pta- mu(cid:173)
`tant was 23% lower in fermentor cultures than observed in
`flask cultures (17 versus 21% in flasks), while in the wild type
`it was 36% lower than that seen in flask cultures (14 versus
`19% in flasks). The data for specific IL-2 accumulation in the
`PTA-competent strain at the induction cell densities tested in
`these studies were consistent with our previous observations
`(10) in which IL-2 expression was less affected by the cell
`density at induction in the 20- to 40-00680 range. Figure 20
`shows that the Pta- mutant accumulated more total IL-2 in
`the fermentor as a result of the increase in specific IL-2
`accumulation combined with continued growth during induc(cid:173)
`tion.
`Effect of Pta- mutation on ethanol, lactate, and pyruvate
`accumulation. In fermentor cultures of the PTA-competent
`strain HW21(pFC54.t) grown in glucose-containing defined
`medium, o-lactate and pyruvate were not produced in large
`amounts. During the 5-h induction period, the concentration
`of o-lactate increased from approximately 1 to approxi(cid:173)
`mately 4 mM, and that of pyruvate increased from approx(cid:173)
`imately 0.1 to approximately 7 mM. There was a higher level
`of accumulation of these acids during growth and induction
`
`BEQ 1029
`Page 4
`
`

`
`1300
`
`BAUER ET AL.
`
`APPL. ENVIRON. MICROBIOL.
`
`20.0 . . . . . - - - - - - - - - - - - - - - - - - ,
`
`c
`
`18.0
`
`16.0
`
`14.0
`
`12.0
`
`10.0
`
`8.0
`
`6.0
`
`4.0
`
`2.0
`
`0.0 .__... _ _.___... _ _.___... _ _.___... _ _.___...____J
`
`4.0 . - - - - - - - - - - - - - - - - - - ,
`
`D
`
`100.0 . - - - - - - - - - - - - - - - - - - - - . . ,
`A
`
`c
`0
`......
`m
`::J
`E
`::J u
`u
`<(
`
`m
`u
`......
`Q.
`0
`
`N
`I
`_j
`
`u -u
`
`Q)
`Q.
`(j)
`
`350.0 . - - - - - - - - - - - - - - - - - - ,
`B
`
`2 300.0
`g
`c 250.0
`.Q
`...... m
`~ 200.0
`Q) u c 8 150.0
`
`Q)
`1U 100.0
`......
`Q) u
`<(
`
`50.0
`
`c
`0
`......
`m
`"5
`E
`::J u
`u
`<(
`
`N
`I
`_j
`
`ro
`......
`0
`f-
`
`0
`
`2
`
`3
`
`4
`
`5
`
`0
`
`2
`
`3
`
`4
`
`5
`
`Time After Induction (h)
`Time After Induction (h)
`FIG. 2. Growth (A), acetate production (B), specific IL-2 production (C), and total IL-2 production (D) in fermentor cultures: Pta- mutant
`MD050L(pFC54.t) (filled symbols) and a Pta nonmutant strain, HW21(pFC54.t) (open symbols) during induction at OD680s of 20 (triangles)
`and 40 (circles). Both strains carried a plasmid which allowed expression of IL-2 when the temperature was shifted from 30 to 37°C at the time
`of induction. The expression level of IL-2 is reported as the weight percentage of total intracellular protein.
`
`when MD050L(pFC54.t) was used. In these fermentor cul(cid:173)
`tures, o-lactate accumulated to 9 mM by the start of induc(cid:173)
`tion and subsequently rose to 15 mM at 3 h of induction
`before falling to 5 mM by the end of the 5-h period. Pyruvate
`accumulation increased from 1.5 to 8.4 mM during the same
`period. Ethanol was not produced in amounts greater that 1
`mM in either culture before or during induction. Clearly, the
`lowered amount of acetate produced in the Pta- mutant was
`not completely compensated for by the slight increases in
`D-lactate and pyruvate production, particularly when the
`differences in cell density are taken into account.
`
`DISCUSSION
`
`The data presented here provide evidence that MD050 is a
`Pta- mutant. At least two groups (3, 9) have reported that
`the method used to select MD050 yields two classes of
`mutants, pta and ack. Both classes of mutants are reported
`to have near-normal aerobic growth rates on glucose, but
`have a greatly reduced growth rate on acetate, particularly
`the pta mutants. Brown et al. (3) showed that pta mutants
`have greatly reduced acetate production, while ack mutants
`accumulate near-normal levels of acetate. This could be
`
`BEQ 1029
`Page 5
`
`

`
`VoL. 56, 1990
`
`PTA- MUTANT OF E. COU SHOWING IMPROVED IL-2 EXPRESSION
`
`1301
`
`because acetylphosphate, which is expected to be accumu(cid:173)
`lated by ack mutants, is unstable at physiological pH and
`temperature and may decompose to acetate. The lack of
`growth of MD050 on acetate-containing plates and its re(cid:173)
`duced acetate accumulation implied that it was a Pta(cid:173)
`mutant rather than an Ack- mutant. The absence of PTA
`activity in MD050 extracts provided further proof. When
`transformed for IL-2 production under control of the tem(cid:173)
`perature-sensitive PL promoter, the Pta- mutant continued
`to grow during induction to a greater extent than its parent.
`It produced less acetate and greater amounts ofiL-2 in terms
`of both specific and total IL-2 accumulation. These proper(cid:173)
`ties made MD050 superior to its parent, MM294-1, as a host
`organism for expression of IL-2 and possibly other heterol(cid:173)
`ogous or homologous protein products.
`We believe that MD050 was nearly devoid of PTA activ(cid:173)
`ity, despite the fact that it still produced some acetate. Two
`lines of evidence support this view: first, only trace amounts
`of PTA activity could be detected in crude extracts; and
`second, strains carrying a known deletion of PTA continued
`to produced acetate. However, the precise location and
`nature of the genetic lesion in MD050 have not been deter(cid:173)
`mined by mapping or other more rigorous means, and we
`cannot completely rule out the possibility that some of the
`remaining acetate production in MD050 was due to residual
`PTA activity. Other possible sources of acetate production
`include the enzyme pyruvate oxidase, which catalyzes the
`oxidative decarboxylation of pyruvate, and spontaneous
`hydrolysis of acetyl-CoA. Our results indicate that pyruvate
`oxidase was not responsible for the remaining acetate pro(cid:173)
`duced by MD050.
`The 27% improvement in specific IL-2 accumulation
`achieved in this study by lowering acetate accumulation,
`using the Pta- mutant, was slightly better than the 17%
`improvement seen in our previous study, which used me(cid:173)
`dium perfusion to keep acetate concentrations low (10). If
`this difference is significant, then it may result from the fact
`that, in the perfusion cultures, although its concentration
`was kept below 100 mM, acetate may still have been
`somewhat inhibitory to maximal IL-2 accumulation. It could
`also be explained if the blockage in the Pta- mutant used in
`the present study led to improved utilization of acetyl-CoA
`through the tricarboxylic acid cycle and oxidative phosphor(cid:173)
`ylation. This may have allowed the formation of more
`intermediates and ATP for IL-2 synthesis than would be
`expected from waste acetate formation. Comparisons of the
`flux rates through the tricarboxylic acid cycle and through
`oxidative phosphorylation before and after induction of IL-2
`synthesis will provide additional information in this regard.
`The reason E. coli makes acetate during aerobic growth on
`glucose is a matter for speculation. It is clear that the bulk of
`the acetate accumulating in the medium during IL-2 expres(cid:173)
`sion came directly from acetyl-CoA via the PT A-ACK
`pathway (i.e., it appeared not to be made directly from
`pyruvate). Presuming that pyruvate formate lyase was not
`active under these conditions, this probably means that
`pyruvate dehydrogenase is sufficiently active to supply both
`the tricarboxylic acid cycle (for oxidative phosphorylation
`and amino acid biosynthetic needs) as well as acetate secre(cid:173)
`tion. Our data show that reducing the acetate formation rate
`by as much as sevenfold by mutation of pta had no measur(cid:173)
`able effects on growth rate. We did, however, observe that
`greater amounts of o-lactate and pyruvate were produced,
`but not in sufficient amounts to make up the difference in
`acetate accumulation. Perhaps the production of these acids
`reflects an imbalance between the cell's glycolytic capacity
`
`and its respiratory capacity (7). The excess glycolytic capac(cid:173)
`ity is shunted into acetate or, failing that, into o-lactate and
`pyruvate. Conditions that result in increased organic acid
`production may be those in which there is reduced respira(cid:173)
`tory flux, exacerbating the imbalance between glycolysis and
`respiration. High-level IL-2 expression may be one such
`condition. It may inhibit respiratory flux directly, by inter(cid:173)
`fering with some component of the respiratory machinery, or
`indirectly, perhaps by excessive shunting of carbon through
`the glyoxylate bypass to provide sufficient intermediates for
`amino acid biosynthesis, but at the expense of e

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket